ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Biomaterials
Volume 28, Issue 10, April 2007, Pages 1889-1899
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1642 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.biomaterials.2006.12.018    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery

Zhiping Zhanga, Sie Huey Leeb and Si-Shen Fenga, b, c, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Chemical & Biomolecular Engineering, Faculty of Engineering, National University of Singapore, Block E5, 02-11, 4 Engineering Drive 4, Singapore 117576, Singapore bNUS Nanoscience & Nanotechnology Initiative (NUSNNI), Faculty of Engineering, National University of Singapore, Block E5, 02-11, 4 Engineering Drive 4, Singapore 117576, Singapore cDivision of Bioengineering, Faculty of Engineering, National University of Singapore, Block E5, 02-11, 4 Engineering Drive 4, Singapore 117576, Singapore

Received 8 November 2006; 
accepted 11 December 2006. 
Available online 2 January 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Doxorubicin-loaded nanoparticles (NPs) of vitamin E TPGS-folate (TPGS-FOL) conjugate and doxorubicin-poly(lactide-co-glycolide)-vitamin E TPGS (DOX-PLGA-TPGS) conjugate were prepared by the solvent extraction/evaporation method for targeted chemotherapy of folate-receptor rich tumors. X-ray photoelectron spectroscopy demonstrated that folate was distributed on the NP surface while the drug molecules were entrapped in the NP matrix. The NPs were found of not, vert, similar350 nm diameter and exhibited a biphasic pattern of in vitro drug release. The cell uptake of the fluorescent NPs and the cell viability of the drug formulated in the NPs were quantitatively investigated, which were found dependent on the content of targeting TPGS-FOL conjugate. The NPs of 50% TPGS-FOL showed cellular uptake by MCF-7 cells 1.5 times higher and by C6 cells 1.7 times higher than the NPs with no TPGS-FOL component after 30 min incubation. The MCF-7 cell viability was found decreased significantly from 50.8% for the drug-loaded NPs of no TPGS-FOL to 8.2% for those of 50% TPGS-FOL after incubation at 100 μm drug concentration at 37 °C. The latter NPs also exhibited much lower IC50 value than the DOX after 24 h incubation, i.e., 19.4 vs. 43.7 μm for MCF-7 cells and 3.3 vs. >100 μm for C6 cells.

Keywords: Cancer nanotechnology; Biodegradable polymers; Doxorubicin; Nanomedicine; Nanobiotechnology

Article Outline

1. Introduction
2. Materials and methods
2.1. Materials
2.2. Synthesis of DOX-PLGA-TPGS
2.3. Synthesis of TPGS-FOL
2.4. Characterization of the synthesized conjugates
2.5. Preparation of DOX-loaded NPs
2.6. Characterization of the DOX-loaded NPs
2.7. Surface chemistry
2.8. In vitro drug release kinetics
2.9. In vitro cytotoxicity
2.10. In vitro cellular uptake of NPs
2.11. Statistical analysis
3. Results and discussion
3.1. Characterization of the synthesized conjugates
3.2. Characterization of DOX-loaded NPs
3.3. Surface chemistry
3.4. In vitro drug release
3.5. In vitro cytotoxicity
3.6. In vitro cellular uptake of NPs
4. Conclusion
Acknowledgements
References










Biomaterials
Volume 28, Issue 10, April 2007, Pages 1889-1899
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.